Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osamu Hashimoto

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
BJU International|November 20, 2010
Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: validation study on the European Association of Urology guidelinesShigeru Sakano, Hideyasu Matsuyama, Kimio Takai, et al.
Journal of Hepatology|April 20, 2004
Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinomaTakuji Torimura, Takato Ueno, Motoaki Kin, et al.
Neoplasia (New York, N.Y.)|March 11, 2011
Metronomic S-1 chemotherapy and vandetanib: an efficacious and nontoxic treatment for hepatocellular carcinomaHideki Iwamoto, Takuji Torimura, Toru Nakamura, et al.
Gastroenterology|April 19, 2006
Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinomaTakuji Torimura, Takato Ueno, Motoaki Kin, et al.
Annals of Surgical Oncology|September 19, 2013
Risk group stratification based on preoperative factors to predict survival after nephroureterectomy in patients with upper urinary tract urothelial carcinomaShigeru Sakano, Hideyasu Matsuyama, Yoriaki Kamiryo, et al.
Cell Reports|November 1, 2018
Activin E Controls Energy Homeostasis in Both Brown and White Adipose Tissues as a HepatokineOsamu Hashimoto, Masayuki Funaba, Kazunari Sekiyama, et al.
Journal of Gastroenterology and Hepatology|April 16, 2014
CD34(+) cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosisToru Nakamura, Takuji Torimura, Hideki Iwamoto, et al.
International Journal of Cardiology|October 18, 2022
Right versus left coronary artery involvement in patients with type A acute aortic dissectionYuichi Saito, Osamu Hashimoto, Takashi Nakayama, et al.
Hinyokika Kiyo. Acta Urologica Japonica|July 4, 2002
[Clinical evaluation of the effect of tamsulosin hydrochloride and cernitin pollen extract on urinary disturbance associated with benign prostatic hyperplasia in a multicentered study]Akihiko Aoki, Katsusuke Naito, Osamu Hashimoto, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
BJU International|November 20, 2010
Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: validation study on the European Association of Urology guidelinesShigeru Sakano, Hideyasu Matsuyama, Kimio Takai, et al.
Journal of Hepatology|April 20, 2004
Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinomaTakuji Torimura, Takato Ueno, Motoaki Kin, et al.
Neoplasia (New York, N.Y.)|March 11, 2011
Metronomic S-1 chemotherapy and vandetanib: an efficacious and nontoxic treatment for hepatocellular carcinomaHideki Iwamoto, Takuji Torimura, Toru Nakamura, et al.
Gastroenterology|April 19, 2006
Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinomaTakuji Torimura, Takato Ueno, Motoaki Kin, et al.
Annals of Surgical Oncology|September 19, 2013
Risk group stratification based on preoperative factors to predict survival after nephroureterectomy in patients with upper urinary tract urothelial carcinomaShigeru Sakano, Hideyasu Matsuyama, Yoriaki Kamiryo, et al.
Cell Reports|November 1, 2018
Activin E Controls Energy Homeostasis in Both Brown and White Adipose Tissues as a HepatokineOsamu Hashimoto, Masayuki Funaba, Kazunari Sekiyama, et al.
Journal of Gastroenterology and Hepatology|April 16, 2014
CD34(+) cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosisToru Nakamura, Takuji Torimura, Hideki Iwamoto, et al.
International Journal of Cardiology|October 18, 2022
Right versus left coronary artery involvement in patients with type A acute aortic dissectionYuichi Saito, Osamu Hashimoto, Takashi Nakayama, et al.
Hinyokika Kiyo. Acta Urologica Japonica|July 4, 2002
[Clinical evaluation of the effect of tamsulosin hydrochloride and cernitin pollen extract on urinary disturbance associated with benign prostatic hyperplasia in a multicentered study]Akihiko Aoki, Katsusuke Naito, Osamu Hashimoto, et al.
Pageof 10